BIOTEST AG VZ O.N./ DE0005227235 /
| 2024-11-15 5:36:27 PM | Chg. +1.000 | Volume | Bid5:36:27 PM | Ask2024-11-15 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 27.500EUR | +3.77% | 3,514 Turnover: 95,983.200 |
-Bid Size: - | -Ask Size: - | 2.41 bill.EUR | 0.05% | 12.69 |
Assets
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 230.7000 | 234.9000 | 243 | 254.9000 | 282.3000 | ||||||
| Intangible Assets | 64.9000 | 62.8000 | 54.6000 | 48.1000 | 50.2000 | ||||||
| Long-Term Investments | 19.3000 | 4.7000 | .2000 | .2000 | 5.2000 | ||||||
| Fixed Assets | 323.4000 | 312.8000 | 314.9000 | 324 | 353.3000 | ||||||
| Inventories | 148.7000 | 153 | 184.2000 | 227 | 246 | ||||||
| Accounts Receivable | 98.3000 | 121 | 96.1000 | 118.5000 | 181.6000 | ||||||
| Cash and Cash Equivalents | 18.5000 | 83.2000 | 57.2000 | 204.4000 | 179.4000 | ||||||
| Current Assets | 308.9000 | 370 | 349 | 562.5000 | 679.3000 | ||||||
| Total Assets | 632.3000 | 682.8000 | 682.3000 | 886.5000 | 1,032.6000 | ||||||
Liabilities
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 42.8000 | 34.7000 | 47.4000 | 51.4000 | 55.5000 | ||||||
| Long-term debt | 132.2000 | 101.3000 | 71 | 226.2000 | 325.8000 | ||||||
| Liabilities to Banks | 161.1000 | 139 | 112.4000 | 231.5000 | 331.9000 | ||||||
| Provisions | 34.8000 | 43.2000 | 35.6000 | 47.7000 | 49.8000 | ||||||
| Liabilities | 324.7000 | 336.1000 | 312.9000 | 425.8000 | 552.4000 | ||||||
| Share Capital | 30 | 30 | 30 | 33.8000 | 33.8000 | ||||||
| Total Equity | 301.6000 | 346.6000 | 369.3000 | 460.6000 | 480.1000 | ||||||
| Minority Interests | 6 | .1000 | .1000 | .1000 | .1000 | ||||||
| Total liabilities equity | 632.3000 | 682.8000 | 682.3000 | 886.5000 | 1,032.6000 | ||||||
Income Statement
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 412.5000 | 422 | 440 | 500.8000 | 582 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 42.9000 | 41.6000 | 44.7000 | 53.8000 | 53.4000 | ||||||
| Interest Income | - | -13.5000 | -9.2000 | -7 | -6.5000 | ||||||
| Income Before Taxes | 28.5000 | 28.6000 | 36.5000 | 47.8000 | 46.9000 | ||||||
| Income Taxes | 8.8000 | 9.9000 | 13.4000 | 15.8000 | 27.7000 | ||||||
| Minority Interests Profit | -2.5000 | -1.8000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 36.9000 | 46.4000 | 33.4000 | 32 | 19.2000 | ||||||
Per Share
Cash Flow
|
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
2013 IFRS in mill. EUR |
2014 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 77.8000 | 72.3000 | 34.7000 | -7.2000 | -11.4000 | ||||||
| Cash Flow from Investing Activities | -16.8000 | 22 | -29.3000 | -32.3000 | -102.4000 | ||||||
| Cash Flow from Financing | -48.3000 | -30.7000 | -31.4000 | 186.9000 | 87.4000 | ||||||
| Decrease / Increase in Cash | 12.7000 | 63.6000 | -26 | 147.4000 | -26.4000 | ||||||
| Employees | 1,721 | 1,774 | 1,870 | 2,160 | 2,332 | ||||||
